ArticleACG case reports journal2026
Long-Term Endoscopic Management of Recurrent High-Grade Dysplasia and Intramucosal Carcinoma in an Inoperable Barrett Patient.
Article in ACG case reports journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Barrett esophagus (BE) with progression to high-grade dysplasia (HGD) or intramucosal carcinoma (IMC) presents a management challenge in patients unfit for surgery. Endoscopic eradication therapies, including radiofrequency ablation (RFA), endoscopic mucosal resection (EMR), and cryotherapy, offer minimally invasive alternatives. This report describes a decade-long course of recurrent HGD and IMC managed entirely through endoscopic interventions in a patient with severe chronic obstructive pulmonary disease, emphasizing the value of personalized and sequential therapeutic strategies. A 71-year-old man with BE and severe chronic obstructive pulmonary disease underwent 18 endoscopic interventions over 10 years, including 5 EMRs, 6 RFAs, and 7 cryotherapy sessions. Despite repeated RFA and EMR, dysplasia recurred multiple times. Cryotherapy initiated after RFA failure achieved complete eradication of dysplasia, intestinal metaplasia, and carcinoma in situ. The patient maintained remission for more than 3 years without recurrence. This case highlights the feasibility of long-term endoscopic management of recurrent HGD and IMC in nonsurgical candidates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.